rediff.com
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Sales 606.54 468.46 432.49 373.11 403.05
Operating profit 120.00 68.69 52.63 33.55 64.33
Interest 0.65 0.35 0.44 0.51 0.55
Gross profit 135.83 79.25 61.21 38.78 71.14
EPS (Rs) 42.49 21.09 15.76 8.88 17.99
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Other income 16.48 10.91 9.01 5.74 7.36
Stock adjustment -67.96 -12.28 15.53 -1.06 -11.12
Raw material 57.88 35.65 49.30 40.31 44.83
Power and fuel - - - - -
Employee expenses 120.24 129.56 117.73 112.48 111.99
Excise - - - - -
Admin and selling expenses - - -20.12 20.12 20.73
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 376.37 246.83 217.43 167.71 172.30
Provisions made - - - - -
Depreciation 7.47 7.88 7.91 9.04 9.18
Taxation 38.55 18.65 13.89 7.55 16.98
Net profit / loss 106.23 52.72 39.40 22.19 44.97
Extra ordinary item 16.43 - - - -
Prior year adjustments - - - - -
Equity capital 5.00 5.00 5.00 5.00 5.00
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 19.79 14.66 12.17 8.99 15.96
GPM (%) 21.80 16.53 13.86 10.24 17.33
NPM (%) 17.05 11.00 8.92 5.86 10.96
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close